Epigenetic Therapies and Biomarkers in Breast Cancer

SIMPLE SUMMARY: Epigenetic therapies are promising agents for overcoming clinical resistance to conventional treatments in breast cancer. In the assessed trials, the use of epigenetic therapies for the management of breast cancer has not translated from the pre-clinical to clinical setting. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Lauren Julia, Achinger-Kawecka, Joanna, Portman, Neil, Clark, Susan, Stirzaker, Clare, Lim, Elgene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833457/
https://www.ncbi.nlm.nih.gov/pubmed/35158742
http://dx.doi.org/10.3390/cancers14030474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833457/
https://www.ncbi.nlm.nih.gov/pubmed/35158742
http://dx.doi.org/10.3390/cancers14030474

Ejemplares similares